6-Hydroxydopamine hydrobromide

Independent reference data for 6-Hydroxydopamine hydrobromide (CAS 636-00-0), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

• Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
• Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.

Synonyms and trade names

6-Hydroxydopamine hydrobromide; 636-00-0; Oxidopamine hydrobromide; TWC1D4W0WB; 1,2,4-Benzenetriol, 5-(2-aminoethyl)-, hydrobromide; NSC-238469; DTXSID30212972; 1,2,4-BENZENETRIOL, 5-(2-AMINOETHYL)-, HYDROBROMIDE (1:1); Hydrobromide, Oxidopamine; RefChem:168921; DTXCID60135463; 211-247-0; 6-hydroxydopamine hbr; Oxidopamine (hydrobromide); 6-OHDA HBr; 5-(2-aminoethyl)benzene-1,2,4-triol hydrobromide

GHS hazard classification

What the public record says

6-Hydroxydopamine hydrobromide · CAS 636-00-0 · C8H12BrNO3. UNII TWC1D4W0WB.

Source: PubChem / Wikidata; the batch COA governs where values differ.